Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Morocco to roll out antimalarials against coronavirus

      Morocco to roll out antimalarials against coronavirus

      Medical Dialogues Bureau26 March 2020 9:15 AM IST
      Rabat: Morocco has authorized hospitals to use antimalarial drugs in treating the new coronavirus, according to a document seen by AFP, as scientists...
      Eli Lilly delays its clinical trials during Coronavirus pandemic

      Eli Lilly delays its clinical trials during Coronavirus pandemic

      Medical Dialogues Bureau25 March 2020 3:00 PM IST
      Indianapolis: Eli Lilly and Company has provided an update on the company's clinical trial activities in light of the COVID-19 pandemic. The company...
      Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals

      Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals

      Medical Dialogues Bureau25 March 2020 2:00 PM IST
      Tokyo: Japanese biopharmaceutical firm Anges Inc said on Tuesday that it and Osaka University had completed the development of a DNA vaccine against...
      Government appeals to various industry bodies, manufacturers to streamline supply of Body Coveralls, N-95 Masks, other PPE for healthcare workers

      Government appeals to various industry bodies, manufacturers to streamline supply of Body Coveralls, N-95 Masks, other PPE for healthcare workers

      Medical Dialogues Bureau25 March 2020 1:35 PM IST
      Delhi: With rising cases of coronavirus in the country, the Government has appealed to various industry bodies, manufacturers to streamline...
      Invest India Business Immunity Platform launched to helping businesses withstand COVID-19

      Invest India Business Immunity Platform launched to helping businesses withstand COVID-19

      Medical Dialogues Bureau25 March 2020 1:26 PM IST
      Delhi: Invest India, India's national Investment Promotion & Facilitation Agency, under the Ministry of Commerce and Industry has launched The...
      Immediate prohibition on export of all ventilators, artificial respiratory apparatus, oxygen therapy apparatus, breathing device as well as sanitizers

      Immediate prohibition on export of all ventilators, artificial respiratory apparatus, oxygen therapy apparatus, breathing device as well as sanitizers

      Medical Dialogues Bureau25 March 2020 1:21 PM IST
      Delhi: In its efforts to fight the COVID-19 pandemic, the Government has prohibited the export of all ventilators, including any artificial...
      Bayer and Curadev sign research collaboration and license agreement for STING antagonists

      Bayer and Curadev sign research collaboration and license agreement for STING antagonists

      Medical Dialogues Bureau25 March 2020 11:15 AM IST
      Berlin & New Delhi: Bayer and Curadev Pvt. Ltd., a drug discovery company based in India, has announced a research collaboration and license...
      Mylab gets DCGI commercial approval for COVID-19 test kit

      Mylab gets DCGI commercial approval for COVID-19 test kit

      Medical Dialogues Bureau24 March 2020 1:19 PM IST
      New Delhi: Pune-based molecular diagnostics company Mylab Discovery Solutions on Monday said it has received commercial approval from the Central...
      Glenmark divests VWash, a female intimate hygiene wash, to Hindustan Unilever

      Glenmark divests VWash, a female intimate hygiene wash, to Hindustan Unilever

      Medical Dialogues Bureau24 March 2020 1:18 PM IST
      Glenmark launched VWash, a liquid vaginal wash, as an OTC product in 2013
      Gilead puts emergency access to experimental coronavirus drug on hold amid surging demand

      Gilead puts emergency access to experimental coronavirus drug on hold amid surging demand

      Medical Dialogues Bureau24 March 2020 12:35 PM IST
      The drugmaker said in a statement there had been an exponential increase in so-called compassionate-use requests for the drug
      CDSCO issues regulatory pathway for R&D of IVD kit for diagnosis of COVID-19

      CDSCO issues regulatory pathway for R&D of IVD kit for diagnosis of COVID-19

      Medical Dialogues Bureau24 March 2020 11:45 AM IST
      Delhi: Through the recent notice Central Drugs Standard Control Organization(CDSCO), Directorate General of Health Services as apprised about the...
      AstraZeneca gets orphan drug designation for pancreatic cancer drug Lynparza

      AstraZeneca gets orphan drug designation for pancreatic cancer drug Lynparza

      Medical Dialogues Bureau24 March 2020 11:30 AM IST
      UK: AstraZeneca has announced that Lynparza (olaparib) has been granted orphan drug designation (ODD) in Japan for the maintenance treatment of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok